A Pilot Study Using Next-Generation Sequencing in Advanced Cancers: Feasibility and Challenges

• Glen J. Weiss ,

  * E-mail: glen.weiss@ctca-hope.com

  Affiliations Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare (VGPCC), Scottsdale, Arizona, United States of America, The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• Winnie S. Liang,

  Affiliation The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• Michael J. Demeure,

  Affiliations Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare (VGPCC), Scottsdale, Arizona, United States of America, The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• Jeff A. Kiefer,

  Affiliation The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• Galen Hostetter,

  Affiliations The Translational Genomics Research Institute, Phoenix, Arizona, United States of America, Van Andel Research Institute, Grand Rapids, Michigan, United States of America

  ⨯
• Tyler Izatt,

  Affiliation The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• Shripad Sinari,

  Affiliation The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• Alexis Christoforides,

  Affiliation The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• Jessica Aldrich,

  Affiliation The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• Ahmet Kurdoglu,

  Affiliation The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• Lori Phillips,

  Affiliation The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• Hollie Benson,

  Affiliation The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• Rebecca Reiman,

  Affiliation The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• Angela Baker,

  Affiliation The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• Vickie Marsh,

  Affiliation Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare (VGPCC), Scottsdale, Arizona, United States of America

  ⨯
• Daniel D. Von Hoff ,

  Contributed equally to this work with: Daniel D. Von Hoff, John D. Carpten, David W. Craig

  Affiliations Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare (VGPCC), Scottsdale, Arizona, United States of America, The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• John D. Carpten ,

  Contributed equally to this work with: Daniel D. Von Hoff, John D. Carpten, David W. Craig

  Affiliation The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
•  [ ... ],
• David W. Craig

  Contributed equally to this work with: Daniel D. Von Hoff, John D. Carpten, David W. Craig

  Affiliation The Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• [ view all ]
• [ view less ]